XML 68 R57.htm IDEA: XBRL DOCUMENT v3.25.3
FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Narrative) (Details)
1 Months Ended 3 Months Ended 6 Months Ended
Sep. 27, 2024
swap
Sep. 26, 2024
swap
Jun. 15, 2023
swap
Sep. 30, 2022
swap
Sep. 27, 2025
USD ($)
Sep. 27, 2025
USD ($)
Mar. 29, 2025
USD ($)
Apr. 01, 2024
USD ($)
Sep. 23, 2022
USD ($)
Derivative [Line Items]                  
Debt outstanding         $ 1,224,728,000 $ 1,224,728,000 $ 1,224,788,000    
Number of Interest Rate Swaps Remaining | swap 2                
Level 2 | Convertible Senior Notes Due 2026                  
Derivative [Line Items]                  
Convertible notes, fair value         293,600,000 293,600,000 286,300,000    
Level 2 | Convertible Senior Notes Due 2029                  
Derivative [Line Items]                  
Convertible notes, fair value         645,100,000 645,100,000 668,400,000    
Term loan, net of financing fees                  
Derivative [Line Items]                  
Debt outstanding         $ 237,550,000 $ 237,550,000 240,028,000    
Foreign Exchange Contract                  
Derivative [Line Items]                  
Percentage of sales generated outside the US         26.60% 25.60%      
Maturity period for foreign currency contracts           1 year      
Interest Rate Swap                  
Derivative [Line Items]                  
Number of interest rate swaps entered | swap       4          
Derivative, percentage of notional value of debt 80.00%                
Derivative, blended fixed interest rate 3.31%                
Notional amount         $ 201,892,000 $ 201,892,000     $ 219,800,000
Number Of Interest Rate Swaps Terminated | swap   2 2            
Designated as Hedging Instrument | Foreign Exchange Contract                  
Derivative [Line Items]                  
Deferred income tax expense (benefit)         0 0      
Designated as Hedging Instrument | Foreign Exchange Contract                  
Derivative [Line Items]                  
Designated foreign currency hedge contracts outstanding         77,000,000.0 77,000,000.0 23,600,000    
Designated as Hedging Instrument | Cash Flow Hedging                  
Derivative [Line Items]                  
Gain (loss) to be reclassified within the next twelve months           1,500,000      
Designated as Hedging Instrument | Interest Rate Swap                  
Derivative [Line Items]                  
Amount of Gain (Loss) Recognized in AOCL           1,600,000      
Not Designated as Hedging Instrument | Foreign Exchange Contract                  
Derivative [Line Items]                  
Non-designated foreign currency hedge contracts outstanding         $ 118,300,000 $ 118,300,000 $ 89,600,000    
Attune Medical                  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                  
Contingent consideration               $ 25,300,000